NEW YORK (GenomeWeb) – Quidel reported after the close of the market on Wednesday that its first quarter revenues decreased 18 percent year over year due to a delayed and weak influenza season.

For the three months ended March 31 revenues decreased to $50.3 million from $61.7 million in Q1 2015, but beat the average analysts' estimate of $49.2 million.

The San Diego-based firm said that total influenza revenues were down 40 percent versus the year-ago period to $20.1 million. This contributed to a 25 percent decrease in infectious disease product revenues.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Apr
05
Sponsored by
Labcyte

This webinar will discuss how acoustic liquid handling can reduce the time and costs for labs performing carrier screening with next-generation sequencing.